An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo
SF1126是一种靶向整合素的泛亚型磷脂酰肌醇-3激酶抑制剂，在体内对多发性骨髓瘤具有活性。
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-013-2078-0
De, Pradip; Dey, Nandini; Terakedis, Breanne; Bergsagel, P Leif; Li, Zhi Hua; Mahadevan, Daruka; Garlich, Joseph R; Trudel, Suzanne; Makale, Milan T; Durden, Donald L
